- Home
- NOW vs NVS Comparison
NOW vs NVS Comparison
Compare NOW & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOW
- NVS
- Stock Information
- Founded
- NOW 2004
- NVS 1895
- Country
- NOW United States
- NVS Switzerland
- Employees
- NOW N/A
- NVS N/A
- Industry
- NOW Computer Software: Prepackaged Software
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- NOW Technology
- NVS Health Care
- Exchange
- NOW Nasdaq
- NVS Nasdaq
- Market Cap
- NOW 214.4B
- NVS 242.8B
- IPO Year
- NOW 2012
- NVS 1991
- Fundamental
- Price
- NOW $947.45
- NVS $122.30
- Analyst Decision
- NOW Strong Buy
- NVS Sell
- Analyst Count
- NOW 32
- NVS 4
- Target Price
- NOW $1,102.13
- NVS $119.00
- AVG Volume (30 Days)
- NOW 1.5M
- NVS 1.1M
- Earning Date
- NOW 10-22-2025
- NVS 10-28-2025
- Dividend Yield
- NOW N/A
- NVS 2.12%
- EPS Growth
- NOW 43.57
- NVS N/A
- EPS
- NOW 7.95
- NVS 6.85
- Revenue
- NOW $12,057,000,000.00
- NVS $55,186,000,000.00
- Revenue This Year
- NOW $20.98
- NVS $9.01
- Revenue Next Year
- NOW $18.60
- NVS $2.49
- P/E Ratio
- NOW $119.26
- NVS $17.85
- Revenue Growth
- NOW 21.11
- NVS 12.95
- 52 Week Low
- NOW $678.66
- NVS $96.06
- 52 Week High
- NOW $1,198.09
- NVS $130.46
- Technical
- Relative Strength Index (RSI)
- NOW 56.73
- NVS 42.46
- Support Level
- NOW $928.47
- NVS $122.32
- Resistance Level
- NOW $956.17
- NVS $128.05
- Average True Range (ATR)
- NOW 22.33
- NVS 1.06
- MACD
- NOW 5.31
- NVS -0.97
- Stochastic Oscillator
- NOW 82.60
- NVS 7.11
About NOW ServiceNow Inc.
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.